Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial

[1]  J. Sackellares,et al.  Efficacy and safety of zonisamide: results of a multicenter study , 1993, Epilepsy Research.

[2]  J. W. A. S. Sander,et al.  The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy , 1990, Epilepsy Research.

[3]  G. Tollefson,et al.  Zonisamide-induced mania. , 1990, Psychosomatics.

[4]  M. Dam,et al.  Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. , 1989, British journal of clinical pharmacology.

[5]  J. Wagner,et al.  Zonisamide (CI‐912) and Cognition: Results from Preliminary Study , 1987, Epilepsia.

[6]  U. Juergens.  Simultaneous determiantion of zonisamide and nine other anti-epileptic drugs and metabolites in serum , 1987 .

[7]  P. Crawford,et al.  A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[8]  R. Buchanan,et al.  Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy. , 1986, Therapeutic drug monitoring.

[9]  C. Dodrill,et al.  Zonisamide in Epilepsy: A Pilot Study , 1985, Epilepsia.

[10]  J. Wagner,et al.  Pilot Study of Zonisamide (1,2‐Benzisoxazole‐3‐methanesulfonamide) in Patients with Refractory Partial Seizures , 1985, Epilepsia.

[11]  D. Schmidt.  Two antiepileptic drugs for intractable epilepsy with complex-partial seizures. , 1982, Journal of neurology, neurosurgery, and psychiatry.

[12]  S. Resor,et al.  The Medical treatment of epilepsy , 1992 .

[13]  D. Chadwick.  Gabapentin in partial epilepsy , 1990 .

[14]  T. Shimizu,et al.  Effects and side effects of zonisamide during long-term medication , 1990 .

[15]  T. Kurokawa,et al.  Effects of zonisamide in children with epilepsy , 1988 .

[16]  C. Kamei,et al.  Effects of 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810) and some antiepileptics on the kindled seizures in the neocortex, hippocampus and amygdala in rats. , 1981, Archives internationales de pharmacodynamie et de therapie.

[17]  T. Karasawa,et al.  3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Pharmacological profile. , 1980, Arzneimittel-Forschung.

[18]  K. Yoshida,et al.  3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Electroencephalographic profile. , 1980, Arzneimittel-Forschung.